{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T23:21:16Z","timestamp":1794525676104,"version":"4.9.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T00:00:00Z","timestamp":1405987200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s13023-014-0111-y","type":"journal-article","created":{"date-parts":[[2014,7,21]],"date-time":"2014-07-21T14:40:30Z","timestamp":1405953630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G&gt;A)"],"prefix":"10.1186","volume":"9","author":[{"given":"Hao-Chuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Chieh","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Rong","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiao-Wei","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Pang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Hsiu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuan-Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dau-Ming","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,22]]},"reference":[{"key":"111_CR1","first-page":"3733","volume-title":"The Metabolic and Molecular Bases of Inherited Disease. Volume 3","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Ioannou YA, Eng CM: a-Galactosidase A deficiency: Fabry disease. The Metabolic and Molecular Bases of Inherited Disease. Volume 3. 8th edition. Edited by: Scriver CR, Sly WS, Childs B, Beaudet AL, Valle D, Kinzler KW, Vogelstein B. New York: McGraw-Hill, 2001:3733-3774.","edition":"8"},{"key":"111_CR2","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"YA Zarate","year":"2008","unstructured":"Zarate YA, Hopkin RJ: Fabry\u2019s disease. Lancet. 2008, 372: 1427-1435. 10.1016\/S0140-6736(08)61589-5.","journal-title":"Lancet"},{"key":"111_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF: Prevalence of lysosomal storage disorders. JAMA. 1999, 281: 249-254. 10.1001\/jama.281.3.249.","journal-title":"JAMA"},{"key":"111_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJM199508033330504","volume":"333","author":"S Nakao","year":"1995","unstructured":"Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, Yoshida A, Kuriyama M, Hayashibe H, Sakuraba H, Tanaka H: An atypical variant of Fabry\u2019s disease in men with left ventricular hypertrophy. N Engl J Med. 1995, 333: 288-293. 10.1056\/NEJM199508033330504.","journal-title":"N Engl J Med"},{"key":"111_CR5","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1097\/01.ASN.0000124671.61963.1E","volume":"15","author":"P Kotanko","year":"2004","unstructured":"Kotanko P, Kramar R, Devrnja D, Paschke E, Voigtlander T, Auinger M, Pagliardini S, Spada M, Demmelbauer K, Lorenz M, Hauser AC, Kofler HJ, Lhotta K, Neyer U, Pronai W, Wallner M, Wieser C, Wiesholzer M, Zodl H, F\u00f6dinger M, Sunder-Plassmann G: Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. J Am Soc Nephrol. 2004, 15: 1323-1329. 10.1097\/01.ASN.0000124671.61963.1E.","journal-title":"J Am Soc Nephrol"},{"key":"111_CR6","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","volume":"366","author":"A Rolfs","year":"2005","unstructured":"Rolfs A, Bottcher T, Zschiesche M, Morris P, Winchester B, Bauer P, Walter U, Mix E, Lohr M, Harzer K, Strauss U, Pahnke J, Grossmann A, Benecke R: Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet. 2005, 366: 1794-1796. 10.1016\/S0140-6736(05)67635-0.","journal-title":"Lancet"},{"key":"111_CR7","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.jacc.2007.06.062","volume":"50","author":"L Monserrat","year":"2007","unstructured":"Monserrat L, Gimeno-Blanes JR, Marin F, Hermida-Prieto M, Garcia-Honrubia A, Perez I, Fernandez X, de Nicolas R, de la Morena G, Paya E, Yague J, Egido J: Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2007, 50: 2399-2403. 10.1016\/j.jacc.2007.06.062.","journal-title":"J Am Coll Cardiol"},{"key":"111_CR8","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","volume":"105","author":"B Sachdev","year":"2002","unstructured":"Sachdev B, Takenaka T, Teraguchi H, Tei C, Lee P, McKenna WJ, Elliott PM: Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation. 2002, 105: 1407-1411. 10.1161\/01.CIR.0000012626.81324.38.","journal-title":"Circulation"},{"key":"111_CR9","first-page":"92","volume":"1","author":"KW Chong","year":"2008","unstructured":"Chong KW, Lu YH, Hsu JH, Lo MY, Hsiao CY, Niu DM: High incidence of cardiac variant of Fabry disease in Taiwanese revealed by newborn screening. Taiwan Hum Genet Soc Autumn Symp. 2008, 1: 92-98.","journal-title":"Taiwan Hum Genet Soc Autumn Symp"},{"key":"111_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCGENETICS.109.862920","volume":"2","author":"HY Lin","year":"2009","unstructured":"Lin HY, Chong KW, Hsu JH, Yu HC, Shih CC, Huang CH, Lin SJ, Chen CH, Chiang CC, Ho HJ, Lee PC, Kao CH, Cheng KH, Hsueh C, Niu DM: High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ Cardiovasc Genet. 2009, 2: 450-456. 10.1161\/CIRCGENETICS.109.862920.","journal-title":"Circ Cardiovasc Genet"},{"key":"111_CR11","doi-asserted-by":"publisher","first-page":"780","DOI":"10.2119\/molmed.2012.00002","volume":"18","author":"YH Chien","year":"2012","unstructured":"Chien YH, Lee NC, Chiang SC, Desnick RJ, Hwu WL: Fabry disease: incidence of the common later-onset alpha-galactosidase A IVS4\u2009+\u2009919G\u2013\u2009>\u2009A mutation in Taiwanese newborns\u2013superiority of DNA-based to enzyme-based newborn screening for common mutations. Mol Med. 2012, 18: 780-784. 10.2119\/molmed.2012.00002.","journal-title":"Mol Med"},{"key":"111_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cca.2011.10.023","volume":"413","author":"CL Tai","year":"2012","unstructured":"Tai CL, Liu MY, Yu HC, Chiang CC, Chiang H, Suen JH, Kao SM, Huang YH, Wu TJ, Yang CF, Tsai FC, Lin CY, Chang JG, Chen HD, Niu DM: The use of high resolution melting analysis to detect Fabry mutations in heterozygous females via dry bloodspots. Clin Chim Acta. 2012, 413: 422-427. 10.1016\/j.cca.2011.10.023.","journal-title":"Clin Chim Acta"},{"key":"111_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cca.2013.09.008","volume":"426C","author":"HC Liao","year":"2013","unstructured":"Liao HC, Huang YH, Chen YJ, Kao SM, Lin HY, Huang CK, Liu HC, Hsu TR, Lin SP, Yang CF, Fann CS, Chiu PC, Hsieh KS, Fu YC, Ke YY, Lin CY, Tsai FJ, Wang CH, Chao MC, Yu WC, Chiang CC, Niu DM: Plasma globotriaosylsphingosine (lysoGb3) could be a biomarker for Fabry disease with a Chinese hotspot late-onset mutation (IVS4+919G>A). Clin Chim Acta. 2013, 426C: 114-120. 10.1016\/j.cca.2013.09.008.","journal-title":"Clin Chim Acta"},{"key":"111_CR14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.bbrc.2010.08.006","volume":"399","author":"T Togawa","year":"2010","unstructured":"Togawa T, Kawashima I, Kodama T, Tsukimura T, Suzuki T, Fukushige T, Kanekura T, Sakuraba H: Tissue and plasma globotriaosylsphingosine could be a biomarker for assessing enzyme replacement therapy for Fabry disease. Biochem Biophys Res Commun. 2010, 399: 716-720. 10.1016\/j.bbrc.2010.08.006.","journal-title":"Biochem Biophys Res Commun"},{"key":"111_CR15","first-page":"70","volume":"2011","author":"MJ van Breemen","year":"1812","unstructured":"van Breemen MJ, Rombach SM, Dekker N, Poorthuis BJ, Linthorst GE, Zwinderman AH, Breunig F, Wanner C, Aerts JM, Hollak CE: Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy. Biochim Biophys Acta. 1812, 2011: 70-76.","journal-title":"Biochim Biophys Acta"},{"key":"111_CR16","doi-asserted-by":"crossref","first-page":"e003146","DOI":"10.1136\/bmjopen-2013-003146","volume":"3","author":"HY Lin","year":"2013","unstructured":"Lin HY, Liu HC, Huang YH, Liao HC, Hsu TR, Shen CI, Li ST, Li CF, Lee LH, Lee PC, Huang CK, Chiang CC, Lin CY, Lin SP, Niu DM: Effects of enzyme replacement therapy for cardiac-type Fabry patients with a Chinese hotspot late-onset Fabry mutation (IVS4\u2009+\u2009919G\u2009>\u2009A). BMJ Open. 2013, 3: e003146-doi:10.1136\/bmjopen-2013-003146","journal-title":"BMJ Open"},{"key":"111_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jcma.2013.11.006","volume":"77","author":"HY Lin","year":"2014","unstructured":"Lin HY, Huang YH, Liao HC, Liu HC, Hsu TR, Shen CI, Li ST, Li CF, Lee LH, Lee PC, Huang CK, Chiang CC, Lin SP, Niu DM: Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfa. J Chin Med Assoc. 2014, 77: 190-197. 10.1016\/j.jcma.2013.11.006.","journal-title":"J Chin Med Assoc"},{"key":"111_CR18","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ: Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005, 18: 1440-1463. 10.1016\/j.echo.2005.10.005.","journal-title":"J Am Soc Echocardiogr"},{"key":"111_CR19","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/0735-1097(92)90385-Z","volume":"20","author":"G de Simone","year":"1992","unstructured":"de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH: Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992, 20: 1251-1260. 10.1016\/0735-1097(92)90385-Z.","journal-title":"J Am Coll Cardiol"},{"key":"111_CR20","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1073\/pnas.0712309105","volume":"105","author":"JM Aerts","year":"2008","unstructured":"Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, van Roomen C, Mirzaian M, Wijburg FA, Linthorst GE, Vedder AC, Rombach SM, Cox-Brinkman J, Somerharju P, Boot RG, Hollak CE, Brady RO, Poorthuis BJ: Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci U S A. 2008, 105: 2812-2817. 10.1073\/pnas.0712309105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"111_CR21","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.bbadis.2010.05.003","volume":"1802","author":"SM Rombach","year":"2010","unstructured":"Rombach SM, Dekker N, Bouwman MG, Linthorst GE, Zwinderman AH, Wijburg FA, Kuiper S, Vd Bergh Weerman MA, Groener JE, Poorthuis BJ, Hollak CE, Aerts JM: Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease. Biochim Biophys Acta. 2010, 1802: 741-748. 10.1016\/j.bbadis.2010.05.003.","journal-title":"Biochim Biophys Acta"},{"key":"111_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ymgme.2010.03.020","volume":"100","author":"T Togawa","year":"2010","unstructured":"Togawa T, Kodama T, Suzuki T, Sugawara K, Tsukimura T, Ohashi T, Ishige N, Suzuki K, Kitagawa T, Sakuraba H: Plasma globotriaosylsphingosine as a biomarker of Fabry disease. Mol Genet Metab. 2010, 100: 257-261. 10.1016\/j.ymgme.2010.03.020.","journal-title":"Mol Genet Metab"},{"key":"111_CR23","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s10545-012-9547-1","volume":"36","author":"YH Chien","year":"2013","unstructured":"Chien YH, Bodamer OA, Chiang SC, Mascher H, Hung C, Hwu WL: Lyso-globotriaosylsphingosine (lyso-Gb(3)) levels in neonates and adults with the Fabry disease later-onset GLA IVS4\u2009+\u2009919G\u2009>\u2009A mutation. J Inherit Metab Dis. 2013, 36: 881-885. 10.1007\/s10545-012-9547-1.","journal-title":"J Inherit Metab Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0111-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-014-0111-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0111-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0111-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:45:00Z","timestamp":1630557900000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-014-0111-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,22]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["111"],"URL":"https:\/\/doi.org\/10.1186\/s13023-014-0111-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,22]]},"assertion":[{"value":"28 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"111"}}